BioMAdvanced Diagnostics
Latest round
- Series A
Last raised
- Sep 2023
Total raised
- $0.1M
Investors
- 3
About BioMAdvanced Diagnostics
Based in Nantes, France, and founded in 2021 by Frédéric Pette, Nicolas Bouler, Sophie Brouard, Richard Danger, and Jean-Michel Bouler, BioMAdvanced Diagnostics operates as a healthcare company that provides doctors with diagnostic aid tools in the context of personalized, predictive, and preventive medicine. BioMAdvanced Diagnostics is a developer of clinical diagnostics and biomarker tests used to monitor patients' immune systems. Furthermore, the company provides tests developed by the company provides diagnostic results, and identifies biomarkers to evaluate and diagnose the risk of transplant rejection, allowing clinicians to adapt to changing and modify their patients' treatment.
Who invested in BioMAdvanced Diagnostics
3 investors across 1 round
See all investors in BioMAdvanced Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 26, 2023
Amount
$0.1M
Investors
Questions about BioMAdvanced Diagnostics
Who invested in BioMAdvanced Diagnostics?
BioMAdvanced Diagnostics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioMAdvanced Diagnostics raised?
BioMAdvanced Diagnostics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BioMAdvanced Diagnostics last raise money?
BioMAdvanced Diagnostics's most recent round on record is a Series A, in Sep 2023.
What does BioMAdvanced Diagnostics do?
Based in Nantes, France, and founded in 2021 by Frédéric Pette, Nicolas Bouler, Sophie Brouard, Richard Danger, and Jean-Michel Bouler, BioMAdvanced Diagnostics operates as a healthcare company that provides doctors with diagnostic aid tools in the context of personalized, predictive, and preventive medicine.
Where is BioMAdvanced Diagnostics headquartered?
BioMAdvanced Diagnostics is headquartered in Nantes, France.
Which VCs invest in companies like BioMAdvanced Diagnostics?
Among active investors with capital left to deploy, Index Ventures, Forbion, Balderton Capital and Sofinnova Partners back healthcare companies at BioMAdvanced Diagnostics's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like BioMAdvanced Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.